Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-21

FDA Approved: FENOFIBRATE — Supplemental Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate submitted by Creekwood Pharmaceuticals LLC. The action represents an approved regulatory update for feno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)